IRX2 and neoplasm: IRX2 was identified together with other genes as a GC immune-related transcription factor (IRTF) in a complex analysis of 1136 gastric cancer samples, in which IRTF regulation patterns were associated with clinical phenotypes, tumor immune microenvironment, immunogenicity and prognosis in GC [93].